Get Premium to unlock powerful stock data
Sio Gene Therapies Inc logo

Sio Gene Therapies Inc

$ 0.27 -0.0149 (-5.32%) 10:08 PM EST
P/E:
At Loss
P/B:
0.27
Market Cap:
$ 19.54M
Enterprise V:
$ -58.60M
Volume:
259.14K
Avg Vol (2M):
611.35K
Also Trade In:
Volume:
259.14K
Market Cap $:
19.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
611.35K
Enterprise Value $:
-58.60M
PB Ratio:
0.27
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Sio Gene Therapies Inc
NAICS : 541714 SIC : 2834
130 West 42nd Street, 26th Floor, New York, NY, USA, 10036
Description
Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.
Name Current Vs Industry Vs History
Cash-To-Debt 30.7
Equity-to-Asset 0.82
Debt-to-Equity 0.04
Debt-to-EBITDA -0.04
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.71
9-Day RSI 28
14-Day RSI 27.75
6-1 Month Momentum % -63.41
12-1 Month Momentum % -72.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.95
Quick Ratio 5.95
Cash Ratio 5.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -72.7
Name Current Vs Industry Vs History
ROE % -61.73
ROA % -55.29
ROIC % -1317.94
ROC (Joel Greenblatt) % -3098.56
ROCE % -60.97

Financials (Next Earnings Date:2022-06-09 Est.)

SIOX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:SIOX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.85
Beta 1.51
Volatility % 58.56
14-Day RSI 27.75
14-Day ATR ($) 0.044676
20-Day SMA ($) 0.327795
12-1 Month Momentum % -72.85
52-Week Range ($) 0.2303 - 2.95
Shares Outstanding (Mil) 73.71

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sio Gene Therapies Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More